Digital Health Venture Funding H1 2023

At the close of H1 2023, venture funding in Digital Health continues to stabilize after the pandemic spending spree. Driven by the decline of venture funding in China, Europe has overtaken Asia Pacific for the 2nd place spot. Cumulative Digital Health venture funding across North America, Europe, the Middle East and Asia Pacific decelerated. Here are all funding deals that has occurred in H1 2023. For a complete analysis of Global funding Deals, download your own copy of Galen Growth’s H1 2023 Global Report from https://www.healthtechalpha.com/research/global-digital-health-ecosystem-2023-mid-year-report .

Last Updated: September 20, 2024

Ventures

Venture	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding
Posterity Health	Wellness Information Platform	United States	$ 123.46 B	$ 123.46 B	Series A	$ 7.50 M
Twinical	Decentralised Clinical Trials	France	$ 123.46 B	$ 123.46 B	Seed	undisclosed
01 Life Technology (零一生命)	Bioinformatics	China	$ 123.46 B	$ 123.46 B	Series B	$ 14.12 M
1upHealth	EHR / PHR	United States	$ 123.46 B	$ 123.46 B	Series C	$ 40.00 M
32Co	Physician / Clinic	United Kingdom	$ 123.46 B	$ 123.46 B	Seed	$ 2.71 M
365healthy (妙智康)	Disease Management	China	$ 123.46 B	$ 123.46 B	Angel	$ 1.45 M
4baseCare	Omics Related Diagnosis	India	$ 123.46 B	$ 123.46 B	Pre-A	$ 2.00 M
4D Path	Medical Imaging	United States	$ 123.46 B	$ 123.46 B	Series A	$ 12.97 M
8medical		Nigeria	$ 123.46 B	$ 123.46 B	Seed	$ 0.12 M
98point6	Teleconsultation	United States	$ 123.46 B	$ 123.46 B	Debt Financing	$ 30.72 M

Showing 1 to 10 of 1001 entries